Eckrich MJ, Frangoul H, Knight J, Mosse C, Domm J
Pediatr Transplant. 2012 16 (1)
The development of PTLD is a rare severe adverse event following ASCT. We report on a child with DS who developed PTLD following autologous transplant for relapsed Hodgkin's disease. He was successfully treated with cyclophosphamide, prednisone and rituximab. We also present a comprehensive review of the literature of PTLD in pediatric patients following ASCT.
© 2010 John Wiley & Sons A/S.
MeSH Terms (15)Antibodies, Monoclonal, Murine-Derived Child Child, Preschool Female Humans Immune System Immunosuppression Lymphoma, Large B-Cell, Diffuse Lymphoproliferative Disorders Male Postoperative Complications Remission Induction Rituximab Stem Cell Transplantation Treatment Outcome